NewLink Genetics Corp (NASDAQ:NLNK)

During the Trading Day
39.82 +5.32 / +15.42%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
39.00 -0.82 / -2.06%
Volume: 11.2K

Today’s Trading

Previous close34.50
Today’s open35.38
Day’s range34.40 - 40.99
Average volume (3 months)774,067
Market cap$962.9M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-23.25%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM


% change
TSROTESARO Inc-0.32-1.21%
SAGESAGE Therapeutics In...-4.27-11.20%
EPZMEpizyme Inc-0.46-1.67%
SRPTSarepta Therapeutics...-0.20-0.89%
Data as of 3:59pm ET, 10/22/2014


Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%


Health Technology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa


To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.